Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Barratt

Showing results (211-220 of 318) with videos related to

Pageof 32
Sort By:
Harm Reduction Journal|April 25, 2023
Correction: 'We don't live in a harm reduction world, we live in a prohibition world': tensions arising in the design of drug alertsIsabelle Volpe, Rita Brien, Jasmin Grigg, et al.
Clinical Toxicology (Philadelphia, Pa.)|September 20, 2021
Wastewater analysis for psychoactive substances at music festivals across New South Wales, Australia in 2019-2020Jonathan Brett, Krista J Siefried, Amy Healey, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 3, 1999
Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathyJ Barratt, E M Bailey, K S Buck, et al.
Circulation. Cardiovascular Genetics|November 3, 2012
Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapyAudrey Y Chu, Franco Guilianini, Harald Grallert, et al.
The International Journal on Drug Policy|December 24, 2021
Impacts of changes in alcohol consumption patterns during the first 2020 COVID-19 restrictions for people with and without mental health and neurodevelopmental conditions: A cross sectional study in 13 countriesEmma L Davies, Cheneal Puljevic, Gail Gilchrist, et al.
Harm Reduction Journal|January 9, 2023
'We don't live in a harm reduction world, we live in a prohibition world': tensions arising in the design of drug alertsIsabelle Volpe, Rita Brien, Jasmin Grigg, et al.
Harm Reduction Journal|April 25, 2023
Correction: Co‑designing drug alerts for health and community workers for an emerging early warning system in Victoria, AustraliaRita Brien, Isabelle Volpe, Jasmin Grigg, et al.
Diabetologia|May 17, 2003
IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunityM Walter, E Albert, M Conrad, et al.
Harm Reduction Journal|March 9, 2023
Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, AustraliaRita Brien, Isabelle Volpe, Jasmin Grigg, et al.
Journal of Vascular Surgery|October 1, 1989
Lipid risk factors in patients requiring arterial reconstructionJ M Seeger, S H Silverman, T C Flynn, et al.
Pageof 32

Showing results (211-220 of 318) with videos related to

Sort By:
Pageof 32
Harm Reduction Journal|April 25, 2023
Correction: 'We don't live in a harm reduction world, we live in a prohibition world': tensions arising in the design of drug alertsIsabelle Volpe, Rita Brien, Jasmin Grigg, et al.
Clinical Toxicology (Philadelphia, Pa.)|September 20, 2021
Wastewater analysis for psychoactive substances at music festivals across New South Wales, Australia in 2019-2020Jonathan Brett, Krista J Siefried, Amy Healey, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 3, 1999
Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathyJ Barratt, E M Bailey, K S Buck, et al.
Circulation. Cardiovascular Genetics|November 3, 2012
Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapyAudrey Y Chu, Franco Guilianini, Harald Grallert, et al.
The International Journal on Drug Policy|December 24, 2021
Impacts of changes in alcohol consumption patterns during the first 2020 COVID-19 restrictions for people with and without mental health and neurodevelopmental conditions: A cross sectional study in 13 countriesEmma L Davies, Cheneal Puljevic, Gail Gilchrist, et al.
Harm Reduction Journal|January 9, 2023
'We don't live in a harm reduction world, we live in a prohibition world': tensions arising in the design of drug alertsIsabelle Volpe, Rita Brien, Jasmin Grigg, et al.
Harm Reduction Journal|April 25, 2023
Correction: Co‑designing drug alerts for health and community workers for an emerging early warning system in Victoria, AustraliaRita Brien, Isabelle Volpe, Jasmin Grigg, et al.
Diabetologia|May 17, 2003
IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunityM Walter, E Albert, M Conrad, et al.
Harm Reduction Journal|March 9, 2023
Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, AustraliaRita Brien, Isabelle Volpe, Jasmin Grigg, et al.
Journal of Vascular Surgery|October 1, 1989
Lipid risk factors in patients requiring arterial reconstructionJ M Seeger, S H Silverman, T C Flynn, et al.
Pageof 32